NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x.

纽约--（商业新闻短讯）--IFF（纽约证券交易所代码：IFF）今天宣布，它已经签署了一项最终协议，将其制药解决方案业务部门出售给法国领先的植物成分Roquette，企业价值高达28.5亿美元，相当于企业价值与息税折旧摊销前利润的倍数约为13倍。

IFF’s Pharma Solutions business is a well-established developer and manufacturer of pharmaceutical excipients and includes its Global Specialty Solutions business supporting industrial and methyl cellulosic food applications. The Pharma Solutions business being sold to Roquette is primarily made up of businesses within IFF’s existing Pharma Solutions division, with some adjustments to the perimeter of the transaction designed to align customers, businesses and the manufacturing footprint..

IFF的制药解决方案业务是一家成熟的制药辅料开发商和制造商，包括其支持工业和甲基纤维素食品应用的全球专业解决方案业务。出售给Roquette的制药解决方案业务主要由IFF现有制药解决方案部门内的业务组成，并对交易范围进行了一些调整，以调整客户、业务和制造足迹。。

“We are pleased to reach an agreement with Roquette that will support Pharma Solutions’ next chapter of growth as a trusted partner for the pharmaceutical industry,” said IFF CEO Erik Fyrwald. 'An important next step in our portfolio optimization strategy, the sale of Pharma Solutions, along with other recent actions such as our dividend rightsizing, represents a significant step towards our commitment to reducing debt leverage to 3.0x or below.

IFF首席执行官埃里克·福尔瓦尔（ErikFyrwald）表示：“我们很高兴与罗奎特（Roquette）达成协议，将支持制药解决方案公司（Pharma Solutions）作为制药行业值得信赖的合作伙伴的下一个增长篇章。”我们投资组合优化战略的下一个重要步骤是出售制药解决方案，以及其他近期行动，如我们的股息调整，这是朝着我们将债务杠杆率降低至3.0倍或以下的承诺迈出的重要一步。

This also enables us to increase focus on the core drivers of long-term profitable growth and maximize value for our shareholders. We are grateful for the many contributions of our Pharma colleagues and are confident that with Roquette, the Pharma Solutions business will be well positioned to expand its industry leadership through continued investment in innovation to meet the evolving needs of pharmaceutical manufacturers and developers worldwide.”.

这也使我们能够更加关注长期盈利增长的核心驱动因素，并为股东创造最大价值。我们感谢制药公司同事的众多贡献，并相信有了罗奎特，制药解决方案业务将能够通过持续的创新投资来扩大其行业领先地位，以满足全球制药制造商和开发商不断变化的需求。”。

'We are excited to enter into this partnership with the talented Pharma Solutions team at IFF, which has grown into the go-to partner in the pharmaceutical excipients and specialty solutions markets globally,” said Pierre Courduroux, CEO of Roquette. “The combination of our excipients expertise with IFF Pharma is a fantastic opportunity to become a true global specialist of drug delivery and oral dosage solutions, responding to the needs of our customers and to the demands of patients who are looking for continuously better treatments.”.

Roquette首席执行官皮埃尔·库尔杜鲁（PierreCourduroux）表示：“我们很高兴与IFF的优秀制药解决方案团队建立合作关系，该团队已发展成为全球制药辅料和专业解决方案市场的合作伙伴。”。“我们的赋形剂专业知识与IFF Pharma的结合是一个绝佳的机会，可以成为真正的全球药物输送和口服剂量解决方案专家，满足我们客户的需求以及寻求持续更好治疗的患者的需求。”。

Pharma Solutions operates 10 research and development and/or production sites globally, with approximately 1100 employees, and generated approximately $1B revenue in 2023. IFF and Roquette expect to close the transaction in the first half of 2025, subject to applicable information and/or consultation requirements and customary closing conditions, including regulatory approvals.

Pharma Solutions在全球运营着10个研发和/或生产基地，拥有约1100名员工，2023年产生了约10亿美元的收入。IFF和Roquette预计在2025年上半年完成交易，但须遵守适用的信息和/或咨询要求以及惯例成交条件，包括监管部门的批准。

J.P. Morgan Securities LLC acted as exclusive financial advisor to IFF, Skadden, Arps, Slate, Meagher & Flom LLP acted as counsel, and Evercore as advisor to the board..

J、 P.Morgan Securities LLC担任IFF、Skadden、Arps、Slate、Meagher&Flom LLP的独家财务顾问，Evercore担任董事会顾问。。

Welcome to IFF

欢迎来到IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves.

IFF（纽约证券交易所代码：IFF）是食品、饮料、香水、健康和生物科学、科学和创意领域的行业领导者，它将为更美好的世界创造必要的解决方案，从全球图标到意想不到的创新和体验。凭借艺术的美丽和科学的精确，我们是一个国际思想家的集体，他们与客户合作，为世界渴望的产品带来气味、味道、体验、成分和解决方案。

Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn..

我们将共同为人类和地球做更多的好事。在iff.com、推特、脸书、Instagram和LinkedIn了解更多信息。。